Vor Biopharma Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:VOR) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 142.89 M109.31 M205.37 M176.24 M464.13 M506.75 M 負債合計 46.23 M43.24 M1.71 B2.4 B628.44 M657.17 M 純資産合計 96.66 M66.07 M-1.51 B-2.23 B-164.31 M-150.42 M 負債および純資産合計 142.89 M109.31 M205.37 M176.24 M464.13 M506.75 M 有利子負債合計 —————— 純負債 ——————

ニュース

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR)

Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vor Biopharma Inc. (VOR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:VOR) 2026-01-16

Micron Tech and Citigroup among market cap stock movers on Wednesday

Vor Biopharma、取締役会に2名の投資パートナーを追加

Vor Biopharma adds two investment partners to board of directors

Vor Biopharma (VOR): Initiating Hold Rating On Durable Telitacicept MG Study Data

TDコーウェン、Vor Biopharmaをテリタシセプトの可能性を評価して「買い」で新規カバレッジ開始

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential

Vor Bio、臨床試験資金調達のため1億5000万ドルの私募を実施